GlassScriptPhysician profile
Cynthia Lama
NPI 1528110210
$636.48
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $189 · 2020: $23.71 · 2021: $221 · 2022: $85.25 · 2023: $99.99 · 2024: $17.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $117.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $148.20 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $129.73 | 2019 | |
| Abbvie INC. | $127.51 | 2021-2024 | |
| Amryt Pharma Holdings LTD | $99.99 | 2023 | Mycapssa |
| Allergan, INC. | $37.30 | 2019 | |
| Genentech USA, INC. | $24.13 | 2021 | |
| Amgen INC. | $23.71 | 2020 | |
| Glaxosmithkline, LLC. | $21.82 | 2019 | |
| Viiv Healthcare Company | $12.48 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cynthia Lama listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.